SPECIALIZED PRESS
July 4, 2022
Not intended for U.S. and UK Media – New late-breaking data from Phase III ARASENS trial presented in the Game Changer oral session at the European Association of Urology Congress 2022 (EAU22)
Last updated:
September 1, 2021